(Q44435073)

2 December 2017

0 references

Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis (English)

1 reference

https://api.crossref.org/works/10.1164/RCCM.2302005

2 December 2017

Role of Isoniazid in Once-Weekly Rifapentine Treatment of Pulmonary Tuberculosis (English)

1 reference

31 December 2023

1 reference

1 reference

0 references

Denis Anthony Mitchison

series ordinal

1

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

2 December 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738593

full work available at URL

31 December 2023

https://www.atsjournals.org/doi/pdf/10.1164/rccm.2302005

1 reference

https://api.crossref.org/works/10.1164/RCCM.2302005

American Journal of Respiratory and Critical Care Medicine

31 December 2023

published in

1 reference

2 December 2017

167

1 reference

2 December 2017

10

1 reference

2 December 2017

1298-1299

1 reference

Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine

2 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

Activityin vitroof Rifabutin, FCE 22807, Rifapentine, and Rifampin againstMycobacterium microtiandM. tuberculosisand Their Penetration into Mouse Peritoneal Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.2302005

21 January 2018

Identifiers

DOI

10.1164/RCCM.2302005

1 reference

2 December 2017

1 reference